New on this site

Wish to be informed when changes or additions occur on the Bayer IR website?

Subscribe to the "New on this site" e-mail service.
Subscribe to the "New on this site" RSS feed.

To keep you informed on Investor News we offer our IR News e-mail service: Newsletter

May 28, 2018

Bonds: Bonds Issued

New: Mandatory Convertible Notes due 2019, Notice to the Noteholders 2018-05-28
May 25, 2018

Stock: Dividends

Conforming to the proposal of the Board of Management and the Supervisory Board, the Annual Stockholders’ Meeting on May 25, 2018 passed the resolution to pay a dividend for fiscal 2017 of EUR 2.80 per share.
April 19, 2018

Events: Q1 2018 Conference Call

On the occasion of the publication of our First Quarter 2018 results we will host a conference call for investors and analysts on May 3, 2018 from approx. 2:00 p.m. CEST.
April 18, 2018

Stock: Basic Data

Update: The capital stock of Bayer AG, amounting to Euro 2,196,346,388.48, is divided into 857,947,808 no-par registered shares.
February 28, 2018

Events: FY/Q4 2017 Conference Call

Live Today:
Financial News Conference at approx. 10:00 a.m. CET (9:00 a.m. UTC)
FY/Q4 2017 Investor Conference Call at approx. 2:00 p.m. CET (1:00 p.m. UTC)
February 14, 2018

Events: FY/Q4 2017 Conference Call

On the occasion of the publication of our Full Year and Fourth Quarter 2017 results we will host a conference call for investors and analysts on February 28, 2018 from approx. 2:00 p.m. CET.
October 10, 2017

Events: Q3 2017 Conference Call

On the occasion of the publication of our Third Quarter 2017 results we will host a conference call for investors and analysts on October 26, 2017 from approx. 2:00 p.m. CEST.
September 20, 2017

Stock: ADR Program

On September 20, 2017, Bayer performed an ADR ratio change. With the new ratio, four Bayer ADRs correspond to one Bayer ordinary share.
August 28, 2017

Events: Xarelto COMPASS Data at ESC Congress 2017

Full data from the Phase III COMPASS Study with Xarelto (Rivaroxaban) have been featured in Hot Line presentations at ESC Congress 2017 on August 27, 2017 in Barcelona, Spain. On this occasion we will host a conference call for investors and analysts today, starting at ap-prox. 1:30 p.m. CEST (11:30 a.m. UTC).
August 21, 2017

Events: Xarelto COMPASS Data at ESC Congress 2017

Full data from the Phase III COMPASS Study with Xarelto (Rivaroxaban) will be featured in Hot Line presentations at ESC Congress 2017 on August 27, 2017 in Barcelona, Spain. On this occasion we will host a conference call for investors and analysts on August 28, starting at approx. 1:30 p.m. CEST (11:30 a.m. UTC).
July 12, 2017

Events: Q2 2017 Conference Call

On the occasion of the publication of our Second Quarter 2017 results we will host a conference call for investors and analysts on July 27, 2017 from approx. 2:00 p.m. CEST
May 2, 2017

Bonds: Bonds Issued

New: Mandatory Convertible Notes due 2019, Notice to the Noteholders 2017-05-02
April 28, 2017

Stock: Dividends

Conforming to the proposal of the Board of Management and the Supervisory Board, the Annual Stockholders’ Meeting on April 28, 2017 passed the resolution to pay a dividend for fiscal 2016 of EUR 2.70 per share.
April 18, 2017

Events: Q1 2017 Conference Call

On the occasion of the publication of our First Quarter 2017 results we will host a conference call for investors and analysts on April 27, 2017 from approx. 2:00 p.m. CEST.
February 22, 2017

Overview: Overview

New: Presentation charts for todays FY/Q4 2016 Investor Conference Call
February 22, 2017

Overview: Overview

Live Today:
Financial News Conference at approx. 10:00 a.m. CET (9:00 a.m. UTC)
FY/Q4 2016 Investor Conference Call at approx. 2:00 p.m. CET (1:00 p.m. UTC)
February 21, 2017

Stock: Dividends

Update: Information on the dividend for fiscal 2016
February 15, 2017

Events: FY/Q4 2016 Conference Call

Restatements 2015 / 2016 due to New Regional Reporting Structure

Reporting of the regions has been adjusted to reflect the distribution of responsibilities on the Board of Management.
Sales for Africa/Middle East are now no longer reported together with Latin America but with Europe.
February 8, 2017

Inside Information: Latest Inside Information

Inside Information as of February 08, 2017

Bayer: Phase III COMPASS study with Bayer’s Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early
February 7, 2017

Events: FY/Q4 2016 Conference Call

On the occasion of the publication of our Full Year and Fourth Quarter Quarter 2016 results we will host a conference call for investors and analysts on February 22, 2017 from approx. 2:00 p.m. CET.
October 13, 2016

Events: Q3 2016 Conference Call

On the occasion of the publication of our Third Quarter 2016 results we will host a conference call for investors and analysts on October 26, 2016 from approx. 2:00 p.m. CEST.
September 20, 2016

Events: Meet Management 2016

Today we are hosting our Meet Management Conference for investors and analysts in Cologne, Germany.
September 15, 2016

Events: Meet Management 2016

On September 20, 2016 we will host our Meet Management Conference for investors and analysts in Cologne, Germany.
September 14, 2016

Overview: Overview

Investor Conference Call: Bayer to Acquire Monsanto
Today, September 14, 2016 at 02:00 p.m. CEST / 08:00 a.m. EDT
July 14, 2016

Events: Q2 2016 Conference Call

On the occasion of the publication of our Second Quarter 2016 results we will host a conference call for investors and analysts on July 27, 2016 from approx. 2:00 p.m. CEST.
May 23, 2016

Overview: Overview

LIVE Today, May 23, 2016
Investor Conference Calls: Bayer Offers to Acquire Monsanto
May 23, 2016

News: Ad-hoc Publications

Ad-hoc Announcement dated May 23, 2016:
Bayer Offers to Acquire Monsanto for USD 122 per Share in Cash to Create a Global Leader in Agriculture
April 29, 2016

Stock: Dividends

Conforming to the proposal of the Board of Management and the Supervisory Board, the Annual Stockholders’ Meeting on April 29, 2016 passed the resolution to pay a dividend for fiscal 2015 of EUR 2.50 per share.
April 13, 2016

Events: Q1 2016 Conference Call

On the occasion of the publication of our First Quarter 2016 results we will host a conference call for investors and analysts on April 26, 2016 from approx. 2:00 p.m. CEST.
February 25, 2016

Events: FY/Q4 2015 Conference Call

Live Today:
Financial News Conference at approx. 10:00 CET (9:00 UTC)
FY/Q4 2015 Investor Conference Call at approx. 2:00 p.m. CET (1:00 p.m. UTC)
February 24, 2016

Stock: Dividends

New: Information about the dividend for fiscal 2015
At its meeting on February 24, 2016, the Supervisory Board of Bayer AG approved the Board of Management\'s recommendation that a dividend payment of EUR 2.50 (2014: EUR 2.25) per share be proposed to the Annual Stockholders\' Meeting on April 29, 2016. With 826,947,808 shares entitled to the dividend, the total dividend payment would amount to EUR 2,067 million (2014: EUR 1,861 million), an increase of 11.1 percent.
February 24, 2016

News: Ad-hoc Publications

New: Ad-hoc Announcement according to § 15 WpHG
Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG
February 16, 2016

Overview: Overview

Restatements 2014 / 2015 due to Covestro

With the company’s focus now on the Life Science businesses, a new organizational structure was introduced effective January 1, 2016. The company’s operations are now managed in three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit.

This release provides restated figures for 2014 and Q1-Q3 2015 reflecting these changes in reporting structure. Restated figures for Q4 2015 will be available with the publication of FY 2015 results on February 25, 2016.
February 12, 2016

Events: FY/Q4 2015 Conference Call

On the occasion of the publication of our Full Year and Fourth Quarter Quarter 2015 results we will host a conference call for investors and analysts on February 25, 2016 from approx. 2:00 p.m. CET.
January 4, 2016

Bonds: CP Program

Update: Commercial Paper Program, Amendment as of January 1, 2016
October 1, 2015

News: Ad-hoc Publications

New: Ad-hoc announcement according to § 15 WpHG
Covestro stock market listing: price range and gross proceeds adjusted
September 18, 2015

News: Ad-hoc Publications

New: Ad-hoc Announcement according to § 15 WpHG
Bayer aligns organization with Life Science businesses
August 31, 2015

Events: Finerenone Data at ESC Congress 2015

Findings from the Phase IIb ARTS HF study evaluating Finerenone versus Eplerenone in patients with worsening chronic Heart Failure with Diabetes and/or Chronic Kidney Disease will be presented in a Hot Line Session at the European Society of Cardiology (ESC) congress on August 31, 2015 from 12:00 noon – 01:30 p.m. CEST (10:00 - 11:30 a.m. UTC) in London, UK. On this occasion we will host a conference call for investors and analysts today starting at approx. 2:00 p.m. CEST (12:00 noon UTC).
July 13, 2015

Events: Q2 2015 Conference Call

On the occasion of the publication of our Second Quarter 2015 results we will host a conference call for investors and analysts on July 29, 2015 from approx. 2:00 p.m. CEST.
May 28, 2015

Stock: Participation Program

Update: The BayShare 2015 share participation program for managers and non-managerial employees (incl. apprentices) in Germany
May 27, 2015

Stock: Dividends

Conforming to the proposal of the Board of Management and the Supervisory Board, the Annual Stockholders’ Meeting on May 27, 2015 passed the resolution to pay a dividend for fiscal 2014 of EUR 2.25 per share.
April 16, 2015

Events: Q1 2015 Conference Call

On the occasion of the publication of our First Quarter 2015 results we will host a conference call for investors and analysts on April 30, 2015 from approx. 2:00 p.m. CEST.
March 30, 2015

Bonds: Bonds Issued

Bayer issued a new hybrid bond with a total volume of EUR 1.3 billion.
March 27, 2015

Overview: Overview

The Annual Stockholders’ Meeting will be held at 10.00 CEST (8.00 UTC) on Wednesday, May 27, 2015 at the Cologne Exhibition Center, North Entrance, Hall 9, Deutz-Mülheimer-Strasse 111, 50679 Cologne.
March 19, 2015

Bonds: EMTN Program

New: Debt Issuance Programme Prospectus dated March 19, 2015
February 25, 2015

Stock: Dividends

At its meeting on February 25, 2015, the Supervisory Board of Bayer AG approved the Board of Management\'s recommendation that a dividend payment of EUR 2.25 (2013: EUR 2.10) per share be proposed to the Annual Stockholders\' Meeting on May 27, 2015. With 826,947,808 shares entitled to the dividend, the total dividend payment would amount to EUR 1,861 million (2013: EUR 1,737 million), an increase of 7.1 percent.
February 9, 2015

Events: FY/Q4 2014 Conference Call

On the occasion of the publication of our Full Year and Fourth Quarter Quarter 2014 results we will host a conference call for investors and analysts on February 26, 2015 from approx. 2:30 p.m. CET.
October 20, 2014

Events: Q3 2014 Conference Call

On the occasion of the publication of our Third Quarter 2014 results we will host a conference call for investors and analysts on October 30, 2014 from approx. 2:00 p.m. CET.
October 2, 2014

Bonds: Bonds Issued

The Bayer Group is issuing a jumbo bond in 144A/Reg S format with a volume of USD 7 billion through its subsidiary Bayer U.S. Finance LLC, Pittsburgh, United States. The bond comprises six tranches with short-, mid- and long-term maturities.
September 19, 2014

Stock: Analysts\' Ratings

Update J.P.Morgan Cazenove: Not rated

Deletion Macquarie: Ceased coverage

Update Nord/LB: Downgrade to Hold
September 18, 2014

Events: Conference Call 2014-09-18 Planned Demerger MaterialScience

Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. On this occasion we will host a conference call for investors and analysts today on September 18, 2014 from approx. 4:15 p.m. CEST (2:15 p.m. UTC).
September 18, 2014

News: Ad-hoc Publications

September 18, 2014
Strategic corporate decision: Bayer plans to focus entirely on Life Science businesses
September 18, 2014

Events: Q1 2014 Conference Call

On the occasion of the publication of our First Quarter 2014 results we will host a conference call for investors and analysts on April 28, 2014 from approx. 2:00 p.m. CEST.
September 18, 2014

News: Ad-hoc Publications

September 18, 2014
Strategic corporate decision: Bayer Board of Management plans to focus entirely on Life Science businesses
September 1, 2014

Stock: Participation Program

Update: The BayShare 2014 share participation program for managers and non-managerial employees (incl. apprentices) in Germany
July 15, 2014

Events: Q2 2014 Conference Call

On the occasion of the publication of our Second Quarter 2014 results we will host a conference call for investors and analysts on July 30, 2014 from approx. 2:00 p.m. CEST.
June 5, 2014

Events: Meet Management 2014 NY

New: Meet Management 2014 in New York – Audio recording (MP3) of the presentations hold by Dr. Marijn Dekkers and Erica L. Mann
May 6, 2014

Events: Conference Call 2014-05-06 Acquisition CC Business Merck

Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc. and to engage in a strategic pharma cooperation in the field of soluble guanylate cyclase (sGC) modulators. On this occasion we will host a conference call for investors and analysts on May 6, 2014 from approx. 1:00 p.m. CEST.
April 30, 2014

Events: Q1 2014 Conference Call

On the occasion of the publication of our First Quarter 2014 results we will host a conference call for investors and analysts on April 28, 2014 from approx. 2:00 p.m. CEST.
April 30, 2014

Stock: Dividends

Update: Information about the dividend for fiscal 2013
April 28, 2014

Overview: Overview

New: Presentation charts for todays Q1 2014 Investor Conference Call
April 25, 2014

Events: Q1 2014 Conference Call

On the occasion of the publication of our First Quarter 2014 results we will host a conference call for investors and analysts on April 28, 2014 from approx. 2:00 p.m. CEST.
April 23, 2014

Stock: Dividends

Bayer proposes dividend increase to EUR 1.90 per share for 2012.
April 23, 2014

Stock: Dividends

New: Information about the dividend for fiscal 2013
April 8, 2014

Events: Q1 2014 Conference Call

On the occasion of the publication of our First Quarter 2014 results we will host a conference call for investors and analysts on April 28, 2014 from approx. 2:00 p.m. CEST.
March 20, 2014

Bonds: EMTN Program

New: Debt Issuance Programme Prospectus dated March 19, 2014
March 11, 2014

Bonds: EMTN Program

New: Debt Issuance Programme Prospectus dated March 21, 2013
February 28, 2014

Overview: Overview

Live Today:
Financial News Conference at approx. 10:00 CET (9:00 UTC)
FY/Q4 2013 Investor Conference Call at approx. 2:30 p.m. CET (1:30 p.m. UTC)
February 26, 2014

Stock: Dividends

New: Information about the dividend for fiscal 2013
February 10, 2014

Events: FY/Q4 2013 Conference Call

On the occasion of the publication of our Full Year and Fourth Quarter Quarter 2013 results we will host a conference call for investors and analysts on February 28, 2014 from approx. 2:30 p.m. CET.
January 22, 2014

Bonds: Bonds Issued

New: Bayer issues EUR 2 billion of bonds - The transaction comprises two-year floating-rate tranche and two EUR 750 million fixed-rate bonds with maturities of four and seven years.
December 12, 2013

Overview: Overview

Bayer Investor Relations website relaunched
The website is now available in responsive design which adapts to different screen formats of desktops, laptops and mobile devices.
October 31, 2013

Home:

Live Today: News Conference Call at approx. 10:00 CET (9:00 UTC) Q3 2013 Investor Conference Call at approx. 2:00 p.m. CET (1:00 p.m. UTC)
October 10, 2013

Events: Q3 2013 Conference Call

On the occasion of the publication of our Third Quarter 2013 results we will host a conference call for investors and analysts on October 31, 2013 from approx. 2:00 p.m. CET.
July 31, 2013

Home: Home

Live Today: Q2 2013 Investor Conference Call at 2:00 p.m. CEST (12:00 noon UTC)
July 8, 2013

Events: Q2 2013 Conference Call

On the occasion of the publication of our Second Quarter 2013 results we will host a conference call for investors and analysts on July 31, 2013 from approx. 2:00 p.m. CEST.
June 11, 2013

Events: Meet Management 2013 NY

Neu: Meet Management 2013 in New York - Audio recording (MP3) of the speech held by Erica L. Mann, Head of the Consumer Care Division; followed by discussion.
June 11, 2013

Events: Meet Management 2013 NY

New: Meet Management 2013 in New York - Audio recording (MP3) of the speech held by Dr. Marijn Dekkers, CEO of Bayer AG
April 12, 2013

Bonds: Rating

Update Moody's: Outlook changed to \"Positive\"
April 3, 2013

Events: Q1 2013 Conference Call

On the occasion of the publication of our First Quarter 2013 results we will host a conference call for investors and analysts on April 25, 2013 from approx. 2:00 p.m. CEST.
March 25, 2013

Bonds: EMTN Program

New: Debt Issuance Programme Prospectus dated March 21, 2013
March 18, 2013

Events: Meet Management 2013 LEV

New: Meet Management Investor Handout At approx. 9:00 a.m. CET (8:00 a.m. GMT): Live audio broadcast of the presentation given by Dr. Marijn Dekkers, CEO of Bayer AG
March 13, 2013

Events: Meet Management 2013 LEV

Meet Management 2013 in Leverkusen Tuesday, March 19, 2013 at approx. 9:00 a.m. CET (8:00 a.m. GMT): Live audio broadcast of the presentation given by Dr. Marijn Dekkers, CEO of Bayer AG
February 28, 2013

Events: Overview

New: Details on the Annual Stockholders' Meeting on April 26, 2013
February 28, 2013

Home: Home

New: Presentation Charts for todays FY/Q4 2012 Investor Conference Call
February 28, 2013

Home: Home

New: Q4 2012 Analyst and Investor Briefing Live Today: Financial News Conference at 10:00 a.m. CET Live Today: FY/Q4 2012 Investor Conference Call at 2:30 p.m. CET
February 26, 2013

Stock: Dividends

Bayer proposes dividend increase to EUR 1.90 per share for 2012.

Services